Clinical Trial Update: The Benefits of Immediate Treatment Initiation Without Immunovirological Data Compared to Conventional BIC / FTC / TAF Treatment in Naive Patients With Type 1 HIV (Human Immunodeficiency Virus) Infection [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immediate antiretroviral treatment initiation without immunovirological data versus conventional BIC/FTC/TAF in treatment-naive HIV-1 p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bictegravir/Emtricitabine/Tenofovir Alafenamide (Bictegravir/emtricitabine/tenofovir alafenamide)

Snippet

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Conditions: HIV-1-infection | Phase 4 | Status: COMPLETED